Medical Properties Trust, Inc. (MPT)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $983.46M
Last updated: Nov 17, 2026 at 4:37 PM ET
Medical Properties Trust, Inc. (MPT) Statistics
Medical Properties Trust (MPT) has a market cap of $983.46M and a P/FFO of 3.4x on its 2026 FFO estimate. Its net debt of $8.66B equals 880.66% of its market cap. Its dividend yield is 22.78%.
Total Valuation
Enterprise value is 880.66% above the market cap, as debt exceeds cash.
| Market Cap | $983.46M |
|---|---|
| Enterprise Value | $9.64B |
| Latest price (Nov 17, 2026) | $1.58 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 10, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Last Ex-Dividend Date | Sep 10, 2026 |
| Last Payment Date | Oct 8, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 3.4x on the 2026 FFO estimate of $0.46 a share. Its year-end P/S ranged from 2.4x to 10.6x from 2016 to 2025.
| P/FFO (2026 estimate) | 3.4x |
|---|---|
| P/E Ratio | 4.2x |
| Forward P/E | 17.8x |
| P/S Ratio | 0.9x |
| Forward P/S | 1.0x |
| P/B Ratio | 0.2x |
| P/OCF Ratio | 3.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 7.1x EBITDA.
| EV / Earnings | 38.7x |
|---|---|
| EV / Sales | 9.3x |
| EV / EBITDA | 7.1x |
| EV / EBIT | 9.0x |
Price Statistics
The stock is down 66.28% over 52 weeks and trades 45.14% below its 50-day average.
| Beta (1Y) | 0.87 |
|---|---|
| 52-Week Change | -66.28% |
| 1-Month Change | -44.56% |
| 3-Month Change | -61.09% |
| 6-Month Change | -66.98% |
| 5-Year Change | -89.45% |
| 10-Year Change | -83.86% |
| Total Return (1Y) | -58.60% |
| Total Return (3Y CAGR) | -24.34% |
| Total Return (5Y CAGR) | -35.69% |
| Return vs SPY (1Y) | -78.83% |
| Max Drawdown (1Y) | -74.13% |
| Max Drawdown (3Y) | -74.13% |
| Sharpe Ratio (1Y) | -2.62 |
| Correlation with SPY (1Y) | 0.28 |
| 50-Day Average | $2.88 |
| 200-Day Average | $4.25 |
| 52-Week Range | $1.48 to $6.09 |
| RSI (14 Days) | 17.8 |
| Average Volume (20 Days) | 23.84M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.49x current liabilities, and total debt is 2.00x shareholder equity.
| Current Ratio | 1.49x |
|---|---|
| Quick Ratio | 1.49x |
| Debt / Equity | 2.00x |
| Debt / EBITDA | 6.85x |
| Debt / FCF | 339.22x |
| Interest Coverage | 1.93x |
Returns and Efficiency
Return on invested capital is 7.70% over the last 12 months, against a 5-year average of -0.36%.
| Return on Equity (ROE) | 5.39% |
|---|---|
| Return on Assets (ROA) | 1.73% |
| Return on Invested Capital (ROIC) | 7.70% |
| Return on Capital Employed (ROCE) | 7.65% |
| ROE (5Y Average) | -8.98% |
| ROA (5Y Average) | -2.79% |
| ROIC (5Y Average) | -0.36% |
| Asset Turnover | 0.07x |
| Receivables Turnover | 2.14x |
Scores
MPT has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $0.52 for 2025, the latest reported year. Revenue of $1.03B over the last 12 months is up 10.13% from the 12 months before.
| FFO Per Share (2025) | $0.52 |
|---|---|
| Revenue | $1.03B |
| Revenue Growth (YoY) | +10.13% |
| Gross Profit | $850.86M |
| Operating Income | $568.66M |
| Pretax Income | $246.28M |
| Net Income | $249.13M |
| EBITDA | $1.35B |
| EBIT | $1.07B |
| Reported EPS (TTM) | $0.38 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 32.11% of the $14.39B in total assets.
| Cash and Equivalents | $599.28M |
|---|---|
| Total Debt | $9.26B |
| Net Debt | $8.66B |
| Net Debt Per Share | $14.50 |
| Working Capital | $202.79M |
| Shareholder Equity | $4.62B |
| Book Value Per Share | $7.74 |
| Total Assets | $14.39B |
| Total Liabilities | $9.77B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $222.09M of capital spending, operating cash flow left $27.30M of free cash flow.
| Operating Cash Flow | $249.39M |
|---|---|
| Capital Expenditures | $222.09M |
| Free Cash Flow | $27.30M |
| FCF Per Share | $0.05 |
| Depreciation and Amortization | $298.00M |
| Dividends Paid | $212.21M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 55.11%, against a 5-year average of 47.20%.
| Gross Margin | 82.46% |
|---|---|
| Operating Margin | 55.11% |
| Pretax Margin | 23.87% |
| Net Margin | 24.14% |
| EBITDA Margin | 130.99% |
| EBIT Margin | 103.58% |
| FCF Margin | 2.65% |
| Gross Margin (5Y Average) | 96.65% |
| Operating Margin (5Y Average) | 47.20% |
| Net Margin (5Y Average) | -46.69% |
Growth
FFO per share fell 33.27% a year over 3 years, and revenue 14.27% a year.
| FFO Per Share Growth (3Y CAGR) | -33.27% |
|---|---|
| Revenue Growth (3Y CAGR) | -14.27% |
| Revenue Growth (5Y CAGR) | -4.89% |
| Operating Income Growth (3Y CAGR) | -18.68% |
| Book Value Per Share Growth (2Y CAGR) | -22.43% |
| Tangible Book Per Share Growth (2Y CAGR) | -30.15% |
Dividends and Yields
MPT pays out 69.23% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $0.36 |
|---|---|
| Dividend Yield | 22.78% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -34.23% |
| Dividend Growth (5Y CAGR) | -21.11% |
| Payout Ratio (2025 FFO) | 69.23% |
| FFO Yield (2025) | 32.91% |
| Shareholder Yield | 22.49% |
Peer Position
Against 12 similar companies, MPT has the lowest P/FFO and the 12th highest P/S.
P/FFOPeer median 11.2x
P/S RatioPeer median 5.2x
ROICPeer median 1.87%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +15.81%
Dividend YieldPeer median 4.59%
| P/FFO | 3.4x vs 11.2x median |
|---|---|
| P/S Ratio | 0.9x vs 5.2x median |
| ROIC | 7.70% vs 1.87% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.13% vs +15.81% median |
| Dividend Yield | 22.78% vs 4.59% median |
Analyst Forecast
FFO per share estimates imply 10.13% decline a year over the next 2 years. Consensus estimates put revenue growth at 3.89% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | -10.13% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +3.89% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MPT
What is MPT's market cap?
Medical Properties Trust has a market cap of $983.46M. Its enterprise value, which adds debt and subtracts cash, is $9.64B.
What is MPT's P/E ratio?
Medical Properties Trust has a P/FFO of 3.4x on its 2026 FFO estimate. Its trailing P/E ratio is 4.2x and its forward P/E is 17.8x.
How many shares of MPT are outstanding?
Medical Properties Trust has 597.16M shares outstanding. The count is down 0.62% from a year earlier.
Does MPT pay a dividend?
Yes. Medical Properties Trust pays $0.36 a share a year, a dividend yield of 22.78%.
How much debt does MPT have?
Medical Properties Trust has $9.26B of total debt and $599.28M of cash and equivalents, a net debt position of $8.66B.
MPT pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors